Clinical Trials Sponsored by M.D. Anderson Cancer Center

Total 3828 results

M.D. Anderson Cancer Center

Completed

Melanoma Vaccine With Peptides and Leuprolide

Melanoma

United States
M.D. Anderson Cancer Center

Unknown

Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans

Cancer | Venous Thromboembolism

United States
M.D. Anderson Cancer Center

Completed

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

Ovarian Cancer

United States
M.D. Anderson Cancer Center

Unknown

Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors

Breast Cancer | Colorectal Cancer | Prostate Cancer

United States
M.D. Anderson Cancer Center

Unknown

Six-Minute Walk Test in Patients at High Risk for Complications From Lung Resection

Lung Cancer

United States
M.D. Anderson Cancer Center

Unknown

Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics

Pediatric Cancer

United States
M.D. Anderson Cancer Center

Terminated

Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

Pancreatic Cancer

United States
M.D. Anderson Cancer Center

Completed

Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Doxil, Bevacizumab and Temsirolimus Trial

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Robotic Harvest of the Latissimus Dorsi (LD) Muscles

Cancer | Complications | Surgical Procedure, Unspecified | Other Reconstructive Surgery | Failure of Muscle Graft

United States
M.D. Anderson Cancer Center

Completed

Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

Data Collection of Demographics and Perioperative Care of Patients Undergoing Laparoscopic Surgery

Laparoscopy

United States
M.D. Anderson Cancer Center

Terminated

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Prostate Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease

Lymphoma | Hodgkin's Disease
M.D. Anderson Cancer Center

Terminated

Use of Nesiritide in the Management of Acute Diastolic Heart Failure

Heart Failure | Cardiovascular Disease | Heart Disease | Congestive Heart Failure | Acute Heart Failure | Diastolic Heart Failure
M.D. Anderson Cancer Center

Completed

Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Terminated

Study of Vioxx and Radiation Therapy for Brainstem Glioma

Glioma | Brain Neoplasms

United States
M.D. Anderson Cancer Center

Terminated

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

Pancreatic Neoplasms

United States
M.D. Anderson Cancer Center

Completed

High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

Metastases, Neoplasm | Neuroendocrine Tumors

United States
M.D. Anderson Cancer Center

Completed

Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)

Myelogenous Leukemia, Chronic

United States
M.D. Anderson Cancer Center

Completed

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme

United States
M.D. Anderson Cancer Center

Completed

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Hematologic Neoplasms | Lymphoma, T-Cell | Mycosis Fungoides

United States
M.D. Anderson Cancer Center

Completed

3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia | Leukemia | AML

United States
M.D. Anderson Cancer Center

Withdrawn

Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children

Malignant Neoplasms of Mesothelial and Soft Tissue | Rhabdomyosarcoma, Pelvic | Rhabdomyosarcoma, Abdominal
M.D. Anderson Cancer Center

Completed

Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma

Colorectal Cancer

United States
M.D. Anderson Cancer Center

Terminated

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Myeloma

United States
M.D. Anderson Cancer Center

Completed

Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions

Oral Cancer

United States
M.D. Anderson Cancer Center

Completed

Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

DNA Array Analysis of Patients With Cervical Cancer

Cervical Cancer

United States
M.D. Anderson Cancer Center

Completed

Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy

Cervical Cancer | Endometrial Cancer | Uterine Cancer

United States
M.D. Anderson Cancer Center

Completed

Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer

Head and Neck Cancer

United States
M.D. Anderson Cancer Center

Completed

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

Lymphoma | Leukemia

United States
M.D. Anderson Cancer Center

Completed

Effect of Parathyroidectomy on Sleep

Hyperparathyroidism

United States
M.D. Anderson Cancer Center

Completed

Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies

Advanced Cancer

United States
M.D. Anderson Cancer Center

Terminated

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Leukemia

United States
M.D. Anderson Cancer Center

Withdrawn

Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis

Septic Shock
M.D. Anderson Cancer Center

Completed

Objective Assessment of Technical Skills in Cardiothoracic Surgery

Other Surgical Procedures

United States
M.D. Anderson Cancer Center

Withdrawn

Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery

Brain Tumor
M.D. Anderson Cancer Center

Completed

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

Lymphoma | Hematologic Diseases | Leukemia | Myeloma

United States
M.D. Anderson Cancer Center

Completed

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

Advanced Cancer

United States
M.D. Anderson Cancer Center

Terminated

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Erlotinib in Combination With Pralatrexate in Advanced Malignancies

Solid Tumors | Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies

Lymphoma | Leukemia | Myeloma

United States
M.D. Anderson Cancer Center

Terminated

Hysteroscopic Lymphatic Mapping for Endometrial Cancer

Endometrial Cancer

United States
M.D. Anderson Cancer Center

Terminated

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

Pancreatic Cancer

United States
M.D. Anderson Cancer Center

Terminated

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

Lung Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma

Lymphoma

3

Subscribe